INCYTE CORP - 8-K Filing
Incyte reports Q3 2026 revenue of $1.56B and raises full-year net sales guidance driven by Opzelura and Hematology/Oncology growth. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $INCY
Read the full article at SEC EDGAR
Part of the story Cloudflare Shares Surge Following Strong Q3 Results and Raised Full-Year Guidance (85 articles)